1. Home
  2. BCSF vs CTKB Comparison

BCSF vs CTKB Comparison

Compare BCSF & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bain Capital Specialty Finance Inc.

BCSF

Bain Capital Specialty Finance Inc.

HOLD

Current Price

$12.08

Market Cap

799.8M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.29

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCSF
CTKB
Founded
2015
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
799.8M
652.1M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
BCSF
CTKB
Price
$12.08
$4.29
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
$14.00
$5.63
AVG Volume (30 Days)
574.3K
725.9K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
15.92%
N/A
EPS Growth
N/A
N/A
EPS
1.53
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
$8.01
N/A
Revenue Growth
N/A
17.67
52 Week Low
$11.82
$2.37
52 Week High
$16.82
$6.18

Technical Indicators

Market Signals
Indicator
BCSF
CTKB
Relative Strength Index (RSI) 39.57 44.29
Support Level $11.82 $4.00
Resistance Level $14.53 $4.51
Average True Range (ATR) 0.30 0.18
MACD 0.01 0.04
Stochastic Oscillator 30.27 43.13

Price Performance

Historical Comparison
BCSF
CTKB

About BCSF Bain Capital Specialty Finance Inc.

Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: